Also, the immunofluorescent staining assay was performed to examine Nrf2 expressions, and we expectedly found that M2-CM increased the expression levels of Nrf2 in the GBM cells in a VEGF-dependent manner (Supplementary Figure S5). The gene discussed is VEGFA; the disease is glioblastoma.